{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:02Z","timestamp":1786980482807,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Foundation of Ren Ji Hospital South Campus, School of Medicine, Shanghai Jiao Tong University","award":["2016PWGZR03"],"award-info":[{"award-number":["2016PWGZR03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10067-017-3793-4","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T15:13:23Z","timestamp":1504106003000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["TMA secondary to SLE: rituximab improves overall but not renal survival"],"prefix":"10.1007","volume":"37","author":[{"given":"Fangfang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"issue":"7","key":"3793_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666. \nhttps:\/\/doi.org\/10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"issue":"1","key":"3793_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imj.12935","volume":"46","author":"P Blombery","year":"2016","unstructured":"Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S, Polizzotto MN, Phillips LE, Wood E, Cohney S, committee TTPrs (2016) Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry. Intern Med J 46(1):71\u201379. \nhttps:\/\/doi.org\/10.1111\/imj.12935","journal-title":"Intern Med J"},{"issue":"3","key":"3793_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.hoc.2016.01.009","volume":"30","author":"T Mehmood","year":"2016","unstructured":"Mehmood T, Taylor M, Winters JL (2016) Management of thrombotic microangiopathic hemolytic anemias with therapeutic plasma exchange: when it works and when it does not. Hematol Oncol Clin North Am 30(3):679\u2013694. \nhttps:\/\/doi.org\/10.1016\/j.hoc.2016.01.009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"3793_CR4","first-page":"216","volume":"20","author":"M Schneider","year":"2007","unstructured":"Schneider M (2007) Thrombotic microangiopathy (TTP and HUS): advances in differentiation and diagnosis. Clin Lab Sci 20(4):216\u2013220","journal-title":"Clin Lab Sci"},{"key":"3793_CR5","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1038\/ki.2008.623","volume":"112","author":"BR Forzley","year":"2009","unstructured":"Forzley BR, Clark WF (2009) TTP\/HUS and prognosis: the syndrome and the disease(s). Kidney Int Suppl 112:S59\u2013S61. \nhttps:\/\/doi.org\/10.1038\/ki.2008.623","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"3793_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1526-0968.2002.00390.x","volume":"6","author":"H Baeyer von","year":"2002","unstructured":"von Baeyer H (2002) Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 6(4):320\u2013328","journal-title":"Ther Apher"},{"issue":"6","key":"3793_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1505533","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knobl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D, Investigators T (2016) Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med 374(6):511\u2013522. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1505533","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"3793_CR8","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.lpm.2011.10.023","volume":"41","author":"P Coppo","year":"2012","unstructured":"Coppo P (2012) Thrombotic microangiopathies: from empiricism to targeted therapies. Presse Med 41(3 Pt 2):e101\u2013e104. \nhttps:\/\/doi.org\/10.1016\/j.lpm.2011.10.023","journal-title":"Presse Med"},{"issue":"5","key":"3793_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/pbc.25398","volume":"62","author":"I Wieland","year":"2015","unstructured":"Wieland I, Kentouche K, Jentzsch M, Lothschutz D, Graf N, Sykora KW (2015) Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after rituximab in children and young adults. Pediatr Blood Cancer 62(5):823\u2013829. \nhttps:\/\/doi.org\/10.1002\/pbc.25398","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"3793_CR10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2169\/naika.103.1654","volume":"103","author":"Y Miyakawa","year":"2014","unstructured":"Miyakawa Y (2014) Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 2. Rituximab for ITP and TTP. Nihon Naika Gakkai Zasshi 103(7):1654\u20131659","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"Suppl 1","key":"3793_CR11","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1179\/102453312X13336169155178","volume":"17","author":"M Scully","year":"2012","unstructured":"Scully M (2012) Rituximab in the treatment of TTP. Hematology 17(Suppl 1):S22\u2013S24. \nhttps:\/\/doi.org\/10.1179\/102453312X13336169155178","journal-title":"Hematology"},{"issue":"5","key":"3793_CR12","first-page":"37","volume":"105","author":"P Kafle","year":"2012","unstructured":"Kafle P, Malakoff GL (2012) Coexistence of systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report. Tenn Med 105(5):37\u201338","journal-title":"Tenn Med"},{"issue":"1","key":"3793_CR13","first-page":"109","volume":"21","author":"FA Niaz","year":"2010","unstructured":"Niaz FA, Aleem A (2010) Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Saudi J Kidney Dis Transpl 21(1):109\u2013112","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"3793_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10165-009-0231-8","volume":"20","author":"K Kamiya","year":"2010","unstructured":"Kamiya K, Kurasawa K, Arai S, Maezawa R, Hanaoka R, Kumano K, Fukuda T (2010) Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol 20(1):81\u201385. \nhttps:\/\/doi.org\/10.1007\/s10165-009-0231-8","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3793_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2177\/jsci.31.159","volume":"31","author":"T Miyamura","year":"2008","unstructured":"Miyamura T, Watanabe H, Takahama S, Sonomoto K, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E (2008) Thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus. Nihon Rinsho Men'eki Gakkai Kaishi 31(3):159\u2013165","journal-title":"Nihon Rinsho Men'eki Gakkai Kaishi"},{"issue":"9","key":"3793_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/SMJ.0b013e3181809ebd","volume":"101","author":"A Hundae","year":"2008","unstructured":"Hundae A, Peskoe S, Grimsley E, Patel S (2008) Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus. South Med J 101(9):943\u2013944. \nhttps:\/\/doi.org\/10.1097\/SMJ.0b013e3181809ebd","journal-title":"South Med J"},{"issue":"6","key":"3793_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ncprheum0511","volume":"3","author":"AA Shah","year":"2007","unstructured":"Shah AA, Higgins JP, Chakravarty EF (2007) Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat Clin Pract Rheumatol 3(6):357\u2013362. \nhttps:\/\/doi.org\/10.1038\/ncprheum0511","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4","key":"3793_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/rheumatology\/keq311","volume":"50","author":"MH Chen","year":"2011","unstructured":"Chen MH, Chen MH, Chen WS, Mu-Hsin Chang P, Lee HT, Lin HY, Huang DF (2011) Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan. Rheumatology 50(4):768\u2013775. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keq311","journal-title":"Rheumatology"},{"issue":"5","key":"3793_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/rheumatology\/keq395","volume":"50","author":"F Lansigan","year":"2011","unstructured":"Lansigan F, Isufi I, Tagoe CE (2011) Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology 50(5):824\u2013829. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keq395","journal-title":"Rheumatology"},{"issue":"4","key":"3793_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/rheumatology\/ken510","volume":"48","author":"P Letchumanan","year":"2009","unstructured":"Letchumanan P, Ng HJ, Lee LH, Thumboo J (2009) A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology 48(4):399\u2013403. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ken510","journal-title":"Rheumatology"},{"issue":"1","key":"3793_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/0961203308094360","volume":"18","author":"SK Kwok","year":"2009","unstructured":"Kwok SK, Ju JH, Cho CS, Kim HY, Park SH (2009) Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus 18(1):16\u201321. \nhttps:\/\/doi.org\/10.1177\/0961203308094360","journal-title":"Lupus"},{"issue":"5","key":"3793_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10165-007-0611-x","volume":"17","author":"H Maruoka","year":"2007","unstructured":"Maruoka H, Koga T, Inoue Y, Honda S, Takeo M, Fukuda T, Aizawa H (2007) Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Mod Rheumatol 17(5):426\u2013428. \nhttps:\/\/doi.org\/10.1007\/s10165-007-0611-x","journal-title":"Mod Rheumatol"},{"key":"3793_CR23","doi-asserted-by":"publisher","unstructured":"Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pene F, Presne C, Saheb S, Deligny C, Rousseau A, Feger F, Veyradier A, Coppo P, French Reference Center for Thrombotic M (2016) Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: results of a phase II, multicenter non-comparative study. Am J Hematol. \nhttps:\/\/doi.org\/10.1002\/ajh.24559","DOI":"10.1002\/ajh.24559"},{"issue":"24","key":"3793_CR24","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1182\/blood-2016-04-710475","volume":"127","author":"A Cuker","year":"2016","unstructured":"Cuker A (2016) Adjuvant rituximab to prevent TTP relapse. Blood 127(24):2952\u20132953. \nhttps:\/\/doi.org\/10.1182\/blood-2016-04-710475","journal-title":"Blood"},{"issue":"2","key":"3793_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/08880011003739414","volume":"28","author":"S Jayabose","year":"2011","unstructured":"Jayabose S, Dunbar J, Nowicki TS, Tugal O, Ozkaynak MF, Sandoval C (2011) Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child. Pediatr Hematol Oncol 28(2):167\u2013172. \nhttps:\/\/doi.org\/10.3109\/08880011003739414","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"3793_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.transci.2010.05.002","volume":"43","author":"K Abou-Nassar","year":"2010","unstructured":"Abou-Nassar K, Karsh J, Giulivi A, Allan D (2010) Successful prevention of thrombotic thrombocytopenic purpura (TTP) relapse using monthly prophylactic plasma exchanges throughout pregnancy in a patient with systemic lupus erythematosus and a prior history of refractory TTP and recurrent fetal loss. Transfus Apher Sci 43(1):29\u201331. \nhttps:\/\/doi.org\/10.1016\/j.transci.2010.05.002","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"3793_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2141.2008.07107.x","volume":"141","author":"M Jin","year":"2008","unstructured":"Jin M, Casper TC, Cataland SR, Kennedy MS, Lin S, Li YJ, Wu HM (2008) Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse. Br J Haematol 141(5):651\u2013658. \nhttps:\/\/doi.org\/10.1111\/j.1365-2141.2008.07107.x","journal-title":"Br J Haematol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3793-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T05:16:33Z","timestamp":1515993393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3793-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3793-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]}}}